XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Shares of Common Stock
Common Stock and Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance, beginning of period at Dec. 31, 2016   $ 61,583 $ 17,206 $ (180) $ 78,609
Balance (in shares) at Dec. 31, 2016 6,263,371        
Increase (Decrease) in Shareholders' Equity          
Net income for period     3,406   3,406
Other comprehensive income          
Net unrealized gain on securities available for sale       610 610
Total comprehensive income     3,406 610 4,016
Stock compensation   199     199
Restricted stock award vesting (in shares) 31,559        
Dividend on common stock     (1,511)   (1,511)
Balance, end of period at Jun. 30, 2017   61,782 19,101 430 81,313
Balance (in shares) at Jun. 30, 2017 6,294,930        
Balance, beginning of period at Dec. 31, 2017   61,981 19,711 (292) 81,400
Balance (in shares) at Dec. 31, 2017 6,294,930        
Increase (Decrease) in Shareholders' Equity          
Net income for period     1,933   1,933
Other comprehensive income          
Net unrealized gain on securities available for sale       677 677
Total comprehensive income     1,933 677 2,610
Stock compensation   274     274
Restricted stock award vesting (in shares) 45,630        
FFNM acquisition   34,101     34,101
FFNM acquisition (in shares) 2,146,378        
Capital raise, net of offering costs   32,524     32,524
Capital raise, net of offering costs (in shares) 2,225,807        
Dividend on common stock     (2,042)   (2,042)
Balance, end of period at Jun. 30, 2018   $ 128,880 $ 19,602 $ 385 $ 148,867
Balance (in shares) at Jun. 30, 2018 10,712,745